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Abstract
Ninety percent of people with diabetes have Type 2 diabetes mellitus (T2DM). T2DM is
a complex disease that affects every organ in the body, which makes effective
management of the disease imperative. The American Association of Clinical
Endocrinologist (AACE) and American College of Endocrinology (ACE) strongly
recommended early treatment initiation among the target population to delay disease
progression and complications. The purpose of this evidence-based project was to
examine the impact of using the T2DM management algorithm for effective management
of adults with T2DM over a 3-month period. The shared experience decision-making
model and chronic care model were used as a guide to implement the approach to
practice. Implementation of the diabetes algorithm revealed a significant decrease in
diabetes-related complications from 61.8% before implementation to 34.06% after the
implementation. A pre- and post-design was used to evaluate the impact of the
interventional diabetes education among the 14 participants in the educational session.
Diabetes education showed an increase in the participants’ knowledge of the disease with
a prescore average of 56.91% compared to 90.72% post score. Early identification of
individuals at risk of developing T2DM, an adaptation of the algorithm into practice,
effective patient education, and efficient use of community-based resources, might
decrease the incidence, prevalence, physical and financial burden, and psychosocial
impact of T2DM, and help to bring about positive change by decreasing T2DM treatment
failure.
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Section1: Nature of the Project
Introduction
Type 2 diabetes mellitus (T2DM) is attributed to numerous risk factors such as
genetic disposition, age, socioeconomic factor, and obesity. The ability to identify
individuals with family history of T2DM, and obesity would enable the care provider to
initiate appropriate interventions promptly and delay the progression of the disease. It is
estimated that the onset of T2DM occurs an average of 4 to 7 years before clinical
diagnosis. A high proportion of individuals exhibit evidence of end-organ damage by the
time they are diagnosed (Forouhi & Wareham, 2014). The American Association of
Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE)
strongly recommend early treatment initiation in this population to delay disease
progression and complications (Garber et al., 2017). A step by step management
algorithm by the AACE and ACE could be used by clinicians to initiate treatment in
patients with substancial risk of T2DM promptly. The purpose of this evidence-based
project is to evaluate the impact of early treatment of individual who have substantial risk
of T2DM in delaying the progression of the disease. The goal is early prevention to
prevent or delay the progression to advance diabetic status among the target population.
Prevention is the key to reducing the incidence and prevalence of diseases such as
diabetes by up to 50% (Backholer et al., 2013; Boyle et al., 2010; CDC, 2014). Section 1
of this project proposal will discuss the background, problem statement, purpose,
practice-focus question and project objectives, theoretical frame works, nature of the
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doctoral project, significance of the project, gaps in literature, implications for social
change, and a summary.
Background
The project site is a non-profit primary care setting, in Destin, Florida that serves
undocumented immigrants, homeless, and working Americans who are not able to afford
medical insurance. The patient population at the clinic are predominantly individuals ages
25 and above with low socioeconomic status and at least two chronic diseases such as
hypertension, hyperlipidemia, diabetes, and coronary arterial disease (CAD). In
comparison to patients with other chronic diseases, patients with T2DM are experiencing
an increased rate of treatment failure due to a phenomenon called glycemic burden.
Glycemic burden is a condition in which the patient’s cumulative glycated hemoglobin
(HbA1c) exceeds the specified treatment goal regardless of therapy (Brown, Nichols, &
Perry, 2004).
The organization is currently using traditional guidelines for management of
T2DM. The traditional guidelines do not require treatment initiation unless the patient is
significantly symptomatic which is defined as having a non-healing wound, frequent
infections, sudden weight gain or weight loss, HbA1c value greater than 10% in a routine
blood test, diabetic neuropathy, and elevated urine protein. With the current guidelines,
effective management of T2DM becomes complex because most of the patients have
already developed diabetes-related complications before treatment is initiated.
A retrospective review of patients’ medical records at the clinic over the last 5
years demonstrated that more than 85% of the patients with T2DM were diagnosed late.
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A late diagnosis results in treatment delay and related complications such as diabetic
retinopathy, peripheral diabetic neuropathy, and cardiovascular problems. An established
protocol and guidelines for early diagnosis and prompt management of T2DM are
imperative to the successful management and prevention of complications in adults with
T2DM. Early treatment initiation is necessary to delay the progression and prevent
disease-related complications, in patients with T2DM. The AACE and ACE strongly
recommend early treatment initiation in this population to delay disease progression and
complications (Pfeiffer, 2014; Brown et al., 2004; Garber et al., 2017).
Problem Statement
Aside from numerous physical, psychological, and financial consequences faced
by individuals affected by DM and their families, a long-standing uncontrolled
hyperglycemia places the patient at higher risk for additional microvascular and
macrovascular complications (Herman, 2011; McCulloch, 2014). The project site is a
small non-profit primary care setting serving about 3,200 patients a year. The
organization relies on community-based clinical providers who volunteer at the clinic to
provide medical services to their patients. Currently, the organization has no specific
treatment protocol for patients with T2DM such that the treatment plan and management
is basically at the providers’ discretion. Treatment is not initiated until the patients
become symptomatic as manifested by elevated HbA1c, a non-healing wound, frequent
infections, and sudden weight gain or weight loss. Approximately 85% of the patients
diagnosed with T2DM have one or more diabetes related complications.
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Most of the patients have other comorbidities such as hypertension and
hyperlipidemia that make the management of DM more complex. Based on the T2DM
management algorithm, metformin should be initiated not only as a first line of therapy
for the patient diagnosed with DM but also as a prophylaxis measure for the individual
who has high risk of developing T2DM (Garber et al., 2017). Glucophage (metformin
hydrochloride) is an oral antihyperglycemic agent that improves glucose tolerance in
patients with T2DM by lowering both basal and postprandial plasma glucose (BristolMeyers Squibb, 2017). Metformin is an appropriate drug for the target population
because it does not affect insulin secretion while fasting (Bristol-Meyers Squibb, 2017)
and is available to the patients from the project site at no cost from most of the
neighborhood pharmaceutical companies.
The impact of metformin in prevention of overt diabetes in individuals with high
risk and prevention of complications in individuals diagnosed is well supported by
numerous studies (see Crandall et al, 2008; DeFronzo & Abdul-Ghani, 2011; De
Kruetzenberg et al., 2015; Diabetes Prevention Program Research Group (DPPRG),
2012; Goldberg et al., 2017; Herman, 2011; Herman, 2015; Kelly et al., 2012; Malin,
Gerber, Chipkin, & Braun, 2012; Marutur et al., 2013; Maji, Roy, & Das, 2005; Perreault
et al., 2012). Standardization of care based on the T2DM algorithm would enable the
providers to initiate treatment promptly in individuals with high risk of developing DM.
Purpose Statement
The primary purpose of this evidence-based project was to implement the diabetes
management algorithm as the standard of care for patients with T2DM at the project site
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and establish the benefits of metformin to individuals at risk of developing the disease
based on the diabetes algorithm. The secondary purpose was to increase patients’ and
providers’ awareness of the complexity of T2DM and emphasize the need for early
treatment in individuals with high risk of developing T2DM to delay the progression of
the disease and prevent complications in individuals diagnosed. Adequate understanding
of the disease process for patients and providers would increase the patients’ compliance
to treatment therapy and it would enable the providers to initiate treatment promptly in
patients at risk of developing T2DM. An effective collaboration between patients and
providers is crucial to optimal health care outcomes in the target population.
Practice-Focused Question and Project Objectives
The practice focused question was: Would early initiation of treatment with
metformin based on the AACE and ACE diabetes management algorithms delay the
progression of T2DM in individuals with high risk of developing the disease and prevent
complications in individuals diagnosed with the disease? The first project objective was
to implement the diabetes algorithm as the standardized management guidelines of care
for patients at high risk of developing T2DM as well as patients diagnosed with the
disease to increase providers’ initiation of early treatment. To achieve the objective, a
Power Point presentation on the significance of using the algorithm as the standard of
care for diabetic management to help alleviate the issue of treatment failure was sent to
all care providers via group email. It was also delivered to the providers at the providers’
quarterly meeting. The CDC prediabetes screening test from the National Diabetes
Prevention Program (NDPP) (see Appendix A) and the patient risk assessment tool from
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the ADA (see Appendix B) to help identify individuals at risk of developing T2DM and
initiate immediate treatment dialogue with the patients were provided to care providers.
The number of patients at risk of developing T2DM who were treated based on the
traditional guidelines was collected over a 3-month period prior to the implementation of
the algorithm and compared to the number of patients who were started on metformin and
or referred to the community-based diabetes prevention program based on the algorithm
for a 3-month period after implementation of the algorithm. Provider competency in the
disease process and management of patients diagnosed with T2DM is imperative to
actively engage patients in the context of patient-centered care and achieve optimal
outcomes (Bernabeo & Holmboe, 2013).
The second project objective was to increase the awareness of patients at risk of
developing T2DM about the disease process and its management. Health literacy is the
key to achieving effective chronic disease management and preventive health
management and it strongly depends on patients and providers improved information and
communication practices (Cavanaugh, 2012). The ability of patients to be aware of risks
and potential complications would enable them to make better-informed decisions and
increase compliance with the treatment modality as initiated by their providers based on
the algorithm.
To attain the second objective, a Power Point presentation discussing T2DM, the
disease process, its management, and complications was presented to patients at risk of
developing T2DM. The patients who have a high risk of developing T2DM or were
diagnosed with T2DM in the last 6 to 24 months were selected via the electronic medical
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record (EMR) based on family history of diabetes, age (40 years and above) body max
index (BMI), and existing medical comorbidities, such as hypertension and
hyperlipidemia. They were sent a follow-up letter (see Appendix C) to notify them of
risks and the various treatments available to them at no cost to ask for their participation
in diabetic education that would take place at the project site to improve their knowledge
of the disease and enhance their self-care management. A pre-and post-intervention test
was conducted to evaluate the patients’ level of understanding of T2DM and its
management. A pamphlet version of the power point presentation was also provided to
each participant and it was available in each examination room in both English and
Spanish languages.
The ability of providers and patients to adequately understand the disease process
would increase the patients’ adherence to the treatment modality and promote positive
patients’ outcomes (Cavanaugh, 2012; Adams, 2010). Mutual collaboration between
patients and providers is essential for total glycemic control, effective management of the
disease, complications prevention, medication compliance, and successful patient health
outcomes (McCulloch, 2014; Shrivastava, Shrivastava, & Ramasamy, 2013). In primary
care, patients’ adequate knowledge of the disease process and active participation in their
care is crucial to efficient transition of care from the clinical setting to home environment
(Shrivastava & Ramasamy, 2013; Sayah et al., 2012).
Gap in Practice
Prior to the evidence-based proposal, there was no specific standard of care or
treatment guidelines in place for the management of T2DM at the project site. Disease
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management was basically at the providers’ discretion. Patients were screened for
diabetes when presenting with conditions such as a non-healing wound, frequent
infection, sudden weight gain or weight loss, or an HbA1c value greater than 10% in a
routine blood test. Treatment is then initiated after the result of screening confirmed the
presence of the disease. The length of time from the point at which the patient
experienced the first symptom to the diagnosis and initiation of treatment can be as long
as 9 to 12 months.
An individual could be developing T2DM for as long as 7 years before he or she
presents with the first symptom (Forouhi & Wareham, 2014). However, by the time the
patient is diagnosed, one or more organs may already be affected. With progression of
T2DM, the treatment plan becomes more complex and the prognosis becomes poorer.
Therefore, adaptation of the diabetes management algorithm for the management of
patients with T2DM from the AACE and ACE would enable providers to promptly
initiate treatment based on the algorithm. With early intervention, the progression of
T2DM may be delayed using cost-effective monotherapy such as metformin to achieve
overall positive health care outcomes (Garber et al., 2017). Establishment of a
standardized evidence-based practice (EBP) would bridge the gap in inequality of patient
care and disparities in health care. By using the diabetes mangement algorithm to manage
T2DM at the project site, the patients are able to receive the same quality evidence-based
care just as their counterparts with medical insurance.
Nature of the Doctoral Project

9
The nature of the project was to determine the impact of providers’ adequate use
of the diabetes management algorithm to initiate early treatment in patients with high risk
of developing T2DM at the project site. To evaluate the providers’ utilization of the
algorithm, a comparison of the number of patients at risk of developing type 2 DM who
were started on early treatment collected over a 3-month period prior to the
implementation of the algorithm, to the number of patients who were started on
metformin and referred to the community-based diabetes prevention program based on
the algorithm after a three-month period was completed. The comparison shows a clear
measure of effects of the intervention.
The project also evaluated the knowledge of patients at risk of developing T2DM
its disease process, management, and complications. A quasi-experimental design of
one-group pretest-posttest approach was used to evaluate the increase in patients’
knowledge regarding their management of T2DM. The presentation took place in the
conference room at the project site. The presentation discussed T2DM, it etiology,
contributing factors to the progression and complications of the disease, the importance
of adequate knowledge and self-care management. The information was presented at a
fifth grade level with limited medical verbiage for patients’ comprehension (Badarudeen
& Sabharwal, 2010). The approach enabled the establishment of baseline knowledge
regarding patients’ understanding of the complexity and multi-faceted nature of T2DM.
At the end of the Power Point presentation, the patients were given the posttest. Result of
the pre and post-test were compared to evaluate the change in knowledge of the patients
regarding T2DM. Statistical Package for the Social Science (SPSS) version 24.0 was
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used to compute a paired sample t-test to accurately analyze patients’ knowledge of
T2DM, its disease process, management, and complications.
Significance of the Project
About 29.1 million American are currently diagnosed with diabetes, and the
number could be doubled if total control of T2DM cannot be achieved by the year 2020
(Healthy People 2020, 2011). Prevention is the key to reduce the incidence and
prevalence of diseases such as diabetes by up to 50% (Backholer et al., 2013; Boyle et al.,
2010; CDC, 2014). Healthy People 2020 (2011) said “Through prevention programs,
reduce the disease and economic burden of diabetes, and improve the quality of life for
all persons who have or are at risk for diabetes”.
Use of the diabetes algorithm affords providers the clear evidence from wellconducted studies to deliver an evidence-based quality of care. The guidelines as a
standard of care serve for providers to develop a customized patient plan of care based on
the algorithm and initiate treatment promptly as deemed. Prompt intervention decreases
the burden of poor glycemic control as well as long-term complications of metabolic
syndrome (Backholer et al., 2013). Standardization of care based on the algorithm would
provide consistency in practice and promote effective continuity of care.
Effective patient-provider collaboration of care would not only improve patients’
compliance with the treatment regimen, but also promotes patients’ sense of involvement
in care that leads to the achievement of healthcare goals and positive clinical outcome
(Cavanaugh et al., 2009). By increasing patients’ awareness of the complexity of T2DM,
there should be an increase in positive self-care behaviors, such as dietary modifications
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and routine exercise. Above all, the use of the algorithm will enhance the costeffectiveness of providing care, increase access to care and decrease health disparities
among the target population.
Implications for Social Change
Standardization of diabetes care based on the diabetes management algorithm for
providers, identification of the individuals at risk of developing T2DM, and prompt
initiation of treatment are imperative to decrease treatment failure in the target
population. The providers’ knowledge of the complexity of the disease process would
enable them to screen individuals at risk of developing T2DM, initiate treatment
modalities earlier, and use other community-based resources such as the diabetes
prevention program and medication assistance program to attain the best patient care
outcomes. The success of early treatment and elimination of treatment failure will
improve both short-and long-term outcomes in patients at risk for and currently
diagnosed with T2DM.
Increasing patients’ knowledge and awareness of T2DM is essential to the
achievement of optimal health care outcome. Patients’ adequate understanding of the
disease process will heighten their commitment to treatment modalities and self-care
management. Active patients’ involvement and participation in care would not only
optimize their compliance with care, but also promote their sense of involvement and
ownership of care. Above all, to hinder the progression of T2DM and prevent
complications related to the disease, a robust evidence-based practice such as the diabetes
algorithm must be adopted into practice. Adaptation of the algorithm into practice,
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effective patient-provider collaboration of care and efficient use of community-based
resources are necessary to decrease the incidence, prevalence, physical burden,
psychological impact, financial constraints, and other complications o T2DM.
Summary
The rate of treatment failure of patients diagnosed with T2DM at the project site
is incredibly high because treatment is based on providers’ discretion. The goal was to
change the management of patients diagnosed with T2DM from a treatment-based to a
prevention-based focus. Therefore, standardized and evidence-based guidelines need to
be adapted by providers to ensure a consistent approach to management of T2DM and
earlier initiation of treatment strategies for patients at risk. Adaptation of the diabetes
management algorithm will enable providers to effectively screen patients at risk of
developing T2DM based on their risk factors, initiate treatment early, and make
appropriate referrals to community-based diabetes prevention programs. The nature of
the project was to determine the impact of the providers’ use of the algorithm to initiate
early treatment in patients at risk of developing T2DM and to evaluate the knowledge of
the patients at risk of developing T2DM, its disease process, management, and
complications. The significance of the project to clinical practice is that it provides the
providers a concise and step-by-step evidence-based guideline to develop a customized
patients’ plan of care. The implication of the project to social change is that it increases
the knowledge of both the providers and patients about the complexity of the disease and
the need for early treatment. Mutual understanding of the disease process promotes
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treatment compliance among patients and attainment of optimal healthcare outcomes a
reality in the target population.

14
Section 2: Background and Context
Introduction
T2DM is a very complex disease and its management is cumbersome in addition.
The complexity of the disease process could easily become overwhelming to both
patients and providers. Adequate awareness of the disease process for patients, use of a
standardized treatment guidelines such as the diabetes management algorithm by the
AACE and ACE, early identification of patients at risk of developing T2DM, and
effective use of community-based resources such as the Florida diabetes preventive
program are crucial to effective and efficient management of chronic disease such as
T2DM, thereby eliminating treatment failure. In this section, the shared experience
decision-making model and the chronic care model (CCM) are the two theoretical
frameworks that will be used to systematically integrate the new approach to practice.
The background and content of the EBP, its relevance to nursing practice, the role of the
DNP student, the role of the project team, and the definitions of terms used will be
discussed.
Concepts, Models and Theories
To systematically integrate the new approach to practice, and improve patients’
and providers’ awareness of T2DM and promote patient self-care management and
empowerment, the shared experience decision-making model and CCM were used to
orchestrate the process. The shared decision-making process promotes a collaborative
and joint effort between the health care provider and the patient to arrive at the best
health care choice that is suitable for the individual patient based on the best available
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research evidence, and the patient’s own values. The shared decision-making model
consists of three key concepts which are evidence in clinical practice, incorporation of the
evidence into clinical practice, and emphasis on the individual patient’s value in the
decision-making process (Friesen-Storms et al., 2015).
With about 85% of patients diagnosed with T2DM having at least one diabetes
related complication, the need for EBP and standardized clinical practice for the
management of patients with T2DM is necessary at the project site. The T2DM
management algorithm is essential to meet the need for a robust EBP for effective
management of the target population. Adaptation of the algorithm into clinical practice
would enable providers to identify individuals at risk of developing T2DM and initiate
treatment promptly. Adequate patient education about T2DM becomes the driving force
for patients to be more involved in their plan of care. Patients’ health literacy is vital for
effective contributions to their health care decision-making process. The shared decisionmaking model helped provide a mutual effort between providers and patients to develop a
consensus on screening for T2DM, its diagnosis, and effective interventions based on the
algorithm for best health outcomes. A robust evidence-based practice decision-making
environment must intergrate evidence into the intervention, clinical expertise, and must
incorporate the patient’s value at all levels (see Figure 1).
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Figure 1. EBP Decision-Making Environment Model. From “Shared Decision Making in
Chronic Care in the context of Evidence-Based Practice in Nursing,” by J. H.H.M.
Friesen-Storms, G.J.J.W. Bours, T. V. D. Weijden, and A.J.H.M. Beurskens, 2015,
International Journal of Nursing Studies, 52(1), 393–402.
The CCM is another theoretical framework suitable to promote patients’ personal
empowerment related to self-care and collaboration of care between provider and patient;
and enhance continuity of care in patients with T2DM. The focus of CCM is to enhance
use of available resources, promote patients’ comprehension of disease processes and
promote an upbeat health care team. Its features are establishment of a health system and
organization of health care to provide leadership for securing resources and removing
barriers to care, creation of self-management support to facilitate skills-based learning
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and patient empowerment for patients, promotion of decision support that guides
implementing evidence-based care, development of delivery system designed to
coordinate care processes, provision of clinical information systems to track progress
through reporting outcomes to patients and providers, and enhancement of community
resources and policies that sustains care by using community-based resources and public
health policy (Baptista et al., 2016).
Establishment of a health system and organization of health care to provide
leadership for securing resources and removing barriers to care is the first feature of the
CCM. Lack of standardization of care is one of the contributing factors to treatment
failure in patients with T2DM at the project site. Establishment of standardized treatment
guidelines such as the algorithm for management of T2DM is a change that must be
adopted into practice by the care providers in the organization to alleviate treatment
failure. The organization’s ability to embrace the guidelines would promote safe and high
quality care and management of errors remove barriers to care, and advance quality
control (Baptista et al., 2016).
The second feature of the CCM is the creation of self-management support to
facilitate skills-based learning and patient empowerment. Lack of patient awareness of
T2DM, its disease process, management, and complication are major contributing factors
to poor patient health care outcomes in the target population. Creation of selfmanagement support that facilitate skills-based learning and patient empowerment is
imperative. Adequate patient education that empowers the patients and emphasizes their
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role in effective self-management is necessary for successful achievement of desired
patient health care goals.
Promotion of decision support that guides implementing evidence-based care is
the third feature of the CCM. Inconsistency in management of patients diagnosed with
T2DM and late initiation of treatment in patients with high risk of developing T2DM at
the project site are due to lack of clear evidence-based clinical guidelines such as the
algorithm. Availability of evidence-based clinical guidelines to support clinical decision
promotes consistency in delivery of care. Use of the guidelines will enable the providers
to screen individuals at risk and initiate treatment promptly.
Development of a delivery system designed to coordinate the care processes is
the fourth feature of the CCM. Effective management of T2DM is very complex and a
multidisciplinary team that focuses on individual structured care must be developed.
Development of a delivery system designed to coordinate care process is necessary to
achieve health care goal for patients with T2DM.
The fifth feature of the CCM is the provision of clinical information systems to
track progress through reporting outcomes to patients and providers. Individual patients’
customized plans of care and desired clinical health care goals must be developed.
Provision of clinical information systems that track the progression of patient outcomes
is imperative for efficient and effective management of the diseases.
The sixth and the last feature of the CCM is an enhancement of community
resources and policies that sustains care by using community-based resources and public
health policy. Efficient transition of care from the clinical setting to home environment is
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the ultimate goal in management of patients with chronic disease such as T2DM in
primary care system (Shrivastava & Ramasamy, 2013). Use of community-based
resources such as the state diabetes preventive program, medication assistance program
by the neighborhood pharmaceutical companies, and provision of diagnostic tests by the
community philanthropies are imperative not only to meet the patients’ need but to attain
the best patient care outcomes and sustenance of care. Enhancement of community
resources and policies that sustain care by using community-based resources and public
health policy is essential to efficient and effective management of chronic disease such as
T2DM. Establishment of partnerships between healthcare systems, organization, patients,
families, and the communities are adamant to the successful patient health care outcome
and effective disease management in chronic disease management (see Figure 2).
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Figure 2. Chronic care model from “The Chronic Care Model for Type 2 Diabetes: A
Systematic Review” by D. R. Baptista, A. Wiens, R. Pontarolo, L.Regis, W. C. Torelli
Reis, and C. J. Correr, 2016. Diabetology and Metabolic Syndrome, (8)7, 1-7.
Relevance to Nursing Practice
T2DM is a very complex, and multifaceted disease. The disease process and its
progression are very complicated such that an individual could have the disease for as
long as seven years before the first symptom emerged. By the time the patient is
diagnosed, he or she typically already has developed complications related to the disease
(Forouhi & Wareham, 2014). Due to the depth-of the disease progression before
diagnosis, the disease management become cumbersome and treatment failure ensue.
Clinicians, providers, stakeholders, patients, and families are greatly affected by the
burden of the treatment failure. It is projected that the number of Americans diagnosed
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with diabetes and the government expenditure related to the disease will double by the
year 2020, if no drastic measure is taking to curtail the disease progression (Healthy
People 2020, 2011).
While it is impossible to eliminate the hereditary risk factor of T2DM, risk factors
such as diet and weight can be managed effectively and thereby delay the progression of
the disease and prevent complications related to the disease. Primary prevention is the
key to efficient and effective management of T2DM to prevent individuals at risk of
developing T2DM to overt diabetes. Early treatment would reduce the incidence,
prevalence, economic burden, and improve the quality of life individuals diagnosed or are
at risk of developing T2DM (Healthy People 2020, 2011).
The cost of diabetes and diabetes related complication are another fact that makes
early treatment imperative among the target population. Most of the patients cannot
afford their medications, and they rely on the medication assistance program. The
providers, care managers, and social workers work relentlessly to explore various
pharmaceutical companies for medication assistance and other needs from the community
resources for these patients. Early treatment initiation in individuals with substantial risk
of diabetes with metformin (Garber et al., 2017) noted in the algorithm, is a win-win for
this population. There are few community-based pharmaceutical companies such as
Publix and Winnie Dixie that provide metformin at no cost to patients at the project site.
However, when the disease is advance to class A2 as described by Klemetti et al. (2016)
in which insulin therapy is required to manage the disease, the treatment modality
becomes cumbersome in the target population. Because attainment of insulin from the
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medication assistance program is not guaranteed, which could place the patients at a
disadvantage and the health outcomes become threatened.
T2DM is a composite disease, and individualized patient treatment plan and
ongoing clinical support are essential to attain positive patient health care outcome
(Robertson, 2012). The success of early treatment initiation strongly depends on the
cooperation among clinicians, the organization, and providers. It is imperative that
providers be aware of patients at risk and initiate the dialogue for early intervention
promptly. Adequate and efficient patient education would enable patients to make an
informed decision towards their health. The development of a collaborative care approach
between patients and their providers along with, customized patient-centered plan of care
are the recipes to a successful clinical outcome and attainment of patients’ health care
outcome in the target population.
Local Background and Context
The project site is a clinic operated by a non-profit organization, and providers are
volunteers. The Hope committee does not interfere with the clinical aspect of the clinic
activities. Their focus is to provide the providers with resources to perform the job. The
committee consists of 10 retired nonmedical personnel and two retired public health
personnel. The medical director is a volunteered retired cardiologist. Unlike the
Medicare and Medicaid funded organizations that are required to develop patients’
treatment plan based on a specific guideline, the providers at the project site are not under
a specific guideline and no quality control based on evidence-based practice is in
existence. The treatment plan for patients with T2DM is not begun unless patients
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become symptomatic or the HbA1c is 10% or above. Currently, there are no specific
guidelines or protocols in place for the management of T2DM. The treatment plan and
management is basically at the providers’ discretion. A standard of care for every disease
process must be established, like the diabetes management algorithm and it must be part
of quality core measures for the clinic’s quality of care.
Despite the ongoing global propaganda regarding the impact of T2DM, its
management, and the effect of early treatment in delaying the progression of the disease;
the Florida state legislature has no legislation in place to help speed up the adaptation of
the evidence-based practice into practice by every provider. According to Krieger
(2008), the practice of government and political priorities are the proximal determinants
that govern the distal determinants which are the society’s economy, social patterns,
physical, behavioral, psychosocial, and biological exposures that trigger pathogenic,
processes thereby causing disease. A political ideology that undermines the significance
of health and healthy living is a catalyst for the public’s adverse health care outcome.
The proximal-distal phenomenon creates a class and racial inequality that
differentially affect the living standards, working conditions, and environmental
exposures of the dominant and subordinated classes and racial/ethnic groups (Krieger,
2008). The phenomenon leads to social class inequality and racial/ethnic health
disparities. The only way the proximal-distal phenomenon leading to health disparities
can be eliminated is to have legislation that mandates a standardized, evidence-based
quality of care to all patients regardless of socioeconomic status and racial/ethnic groups.
Definition of Terms
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The following are the definitions of relevant terms used in this paper:
Adenosine Monophosphate-activated Protein Kinase (AMPK): An enzyme that
speed up metabolism and burn fat when activated (De Kreutzenberg et al., 2015).
Athena: A computer system use by the clinic site for clinical decision support
(CDS).
Body Mass Index (BMI): A person’s weight in kilograms divided by the square of
height in meters. It is moderately correlated with more direct measures of body fat
(CDC, 2016).
Diabetes management algorithm: The standard and recommendations guidelines
established by endocrine governing bodies based on the most current clinical evidence for
efficient and effective of diabetes (Garber et al., 2017).
Diabetic nephropathy: Damage to small blood vessels in the kidneys (WHO,
2017)
Peripheral diabetic neuropathy: A dysfunction of cardiac autonomic activity
(Bansal, 2015).
Diabetic retinopathy: Small blood vessel damage to the back layer of the eye, the
retina, leading to progressive loss of vision, even blindness (WHO, 2017).
Euglycemic: Normal blood glucose (or, blood sugar). It is also referred to
as normoglycemia (Bansal, 2015).
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Glycemic burden: A condition in which the patient’s cumulative glycated
hemoglobin (HbA1c) exceeds the specified treatment goal regardless of therapy (Brown,
Nichols, & Perry, 2004).
Glycated hemoglobin (HbA1c): A biochemical marker that is used to monitor the
long-term glycemic control and assess the risk of developing complications (Yedla,
Kuchay, & Mithal, 2015).
Hyperglycemia: When the blood glucose level is too high because the body isn't
properly using or doesn't make the hormone insulin (Hess-Fischl, 2015).
Hypoglycemia: A condition characterized by abnormally low
blood glucose (blood sugar) levels, usually less than 70 mg/dl (McCulloch, & Mulder,
2016).
Overt diabetes: Progression of pre-diabetes condition to full clinical diabetes
stage (Maruthur et al., 2013).
Pre-diabetes: An intermediate state of hyperglycemia with glycemic parameters
above normal but below the diabetes threshold (Bansal, 2015).
Treatment failure: Inability to achieve clinical treatment goal (Brown et al.,
2004).
Type I diabetes: A congenital defect that results in decrease insulin production by
the pancreatic beta cells (Punjab, 2016).
Type II diabetes: Resistance to the action of insulin of different target tissues such
as muscle, liver, and adipose, which ultimately leads to an impaired glucose uptake for
these organs (Punjab, 2016).
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Therapeutic Lifestyle Changes (TLC): Lifestyle component that focuses on
healthy eating pattern, weight management, and increased physical activity (CDC, 2016).
Role of the DNP Student
Clinical prevention and population health for improving the nation’s health is one
of the academic requirements for the Doctor of Nursing Practice (DNP) curriculums
essential for all DNP graduates (AACN, 2006). It is vital for a DNP as an agent of change
and empowerment to develop and promote, health promotion and disease prevention
activities for individuals, aggregates, and population (AACN, 2006). According to Center
for Disease Control and Prevention (CDC) (2015), about half of preventable deaths in the
United States (U.S) are related to unhealthy lifestyle, lack of adequate screening for
diseases, and obesity. The DNP graduate’s ability to engage in leadership that integrate
and institutionalize evidence-based clinical prevention and disease management is
indispensable (AACN, 2006). As a DNP student, I feel compelled and obligated that the
population served at the project site should receive the same quality care and most current
evidence-based standard of care for everybody else in the community regardless of their
socioeconomic status and or racial/ethnic background.
After the approval of the Walden’s Internal Review Board (IRB) to implement the
project and the execution of the project is also approved by the sponsor at the project site,
I met with the team to discuss about the project. Then I developed the schedule and the
activities of the project based on the organization’s hours of operation. I was the project
manager for the project team. As described by Thomas, Jacques, Adams, & KihnemanWooten, (2008) my responsibility as the project manager, includes successful initiation,
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planning, design, execution, monitoring, and evaluation of the project. My goal was to
complete the project in twelve weeks and on time as scheduled without delay or
hindrances. Although the process of a project implementation could be very cumbersome
and challenging, but with these team members on my side, the project it was a success.
Role of the Project Team
Project planning and team development are integral parts and process of a project.
They must be developed and initiated simultaneously with the project (Thomas et al.,
2008). The role of each project team members and effective management of such role is
critical to the successful outcome of the project. The success of any project strongly
depends on well-considered, well-developed, and outstanding, committed team members
(Thomas et al., 2008). I was the project manager, my preceptor was the sponsor as the
director of the organization, and the other team members are the Spanish interpreter, who
is a volunteer at the clinic and the project site care coordinator, who is an employee of the
organization. The role of the Spanish interpreter is very crucial to the project as 50% of
the population served at the project site is Spanish speaking only. The project site care
coordinator coordinates the EMR review and served as the liaison between the project
team, project manager, the patients, providers, and other stakeholders. A well strategic
plan and committed team members are the precursors to a successful project outcome.
Summary
T2DM is identified as one of the complex chronic diseases to manage in primary
care. Its multi faceted disease characteristics required a multidisciplinary team
management to be managed efficiently and effectively. Use of a standardized treatment
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guideline such as the diabetes management algorithm serves as a blue print for a provider
in the identification of patients at risk of developing T2DM. The ability of the providers
to identify individuals at risk would result in prompt treatment initiation. Adequate
patient knowledge of the disease process and judicial use of community-based resources
such as the diabetes preventive program are essential to the effective and efficient
management of T2DM, thereby alleviating treatment failure in the target population. The
shared experience decision-making model demonstrates that a robust EBP decision
environment must integrate evidence of the clinical intervention, clinical expertise, and
incorporation of patient’s value at all level to achieve the utmost clinical outcome. The
CCM framework promotes patients’ empowerment related to self-care management, a
collaboration of care between providers, patients, organization, and continuity of care in
patients with T2DM. The background and content of the EBP were identified as lack of
standard of care for the management of T2DM by the providers and the need to adapt the
algorithm to decrease treatment failure. The relevance of the project to the nursing
practice is a reduction the incidence; prevalence, economic burden, and improvement of
the quality of life of individuals diagnosed or that are at risk of developing T2DM. My
role as an agent of change and empowerment was to develop and promote health
promotion and disease prevention activities for individuals, aggregates, and target
population. The role of every project team members and effective management of such
role was critical to the successful outcome of the project.
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Section 3: Collection and Analysis of Evidence
Introduction
The purpose of this evidence-based project are to implement the diabetes
algorithm as the standard of care for the management of T2DM at the project site,
increase patients’ and providers’ awareness of the complexity of the disease, the need for
early treatment of individuals at high risk of developing T2DM to delay the progression
of the disease in individuals at risk of developing the disease, and prevention of
complications related to the disease in diagnosed individuals. The clinic has experienced
significant level of treatment failure with about 85% of patients diagnosed with T2DM
having one or more additional microvascular and macrovascular complications due to a
lack of standardized treatment protocol. A robust and standardized evidence-based
practice is needed to alleviate the gap in treatment failure in the target population.
Numerous studies support early treatment of individuals with a high risk of developing
T2DM with metformin based on the algorithm (see Herman, 2015; Kreutzzenberg et al.,
2015; Malin et al., 2012; Maruthur et al., 2013). An extensive review of literature is
discussed in this section, in addition to sources of evidence, the practice-focused
question, evidence generated for the doctoral project, and analysis and synthesis of the
project.
Practice-Focused Question
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Currently, there is no specific guideline or protocol for the management of T2DM
at the project site. Management of the target population is basically at the individual
provider’s discretion. The lack of standardization of treatment results in treatment failure
and glycemic burden. An established standard of care is imperative to address these
issues. The purpose of this project was to implement an evidence-based standard of care
such as the algorithm for patients T2DM, to prevent patients at risk of developing T2DM
from developing overt diabetes and diabetes-related complications in individuals
diagnosed with the disease. Hence, the practice-focused question was: Would early
initiation of treatment with metformin based on the AACE and the ACE diabetes
management algorithm delay the progression of T2DM in individuals with a high risk of
developing the disease and prevent complications in individuals diagnosed with the
disease?
Sources of Evidence
The review of literature for evidence was conducted using the databases PubMed,
MEDLINE, CINHAL, National Institutes of Health (NIH), CDC, and the Cochrane
Library via Walden University to identify studies that focused on the effects of early
intervention in patients with T2DM and used metformin as a prophylaxis in patients with
potential risks of developing diabetes and pre-diabetes based on the diabetes management
algorithm. Studies that examine the cost-effectiveness of metformin were also identified.
The key terms and combination of words used were: diabetes, type II diabetes,
complications, risk factors, and cost of care. Searched articles were published between
2006 and 2017 to obtain the most current evidence-based and peer-reviewed articles. The
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studies were selected based on the aim of the study, outcome of the study, population
sample size, research design, and levels of evidence, strengths and weaknesses of each
study. The initial results of the search generated 2,800 articles related to prevention and
early treatment of diabetes. The number of the article was narrowed down to 500 after
adding metformin as the intervention for prevention and early treatment of T2DM. The
articles were further narrowed down to 10 by selecting articles in which metformin was
used as either the primary preventive intervention for T2DM or as an adjunct with
another intervention such as lifestyle changes based on the diabetes algorithm.
Literature Review
Maruthur et al. (2013) examined the relationship between early measures
of weight and glucose control in patients with a high risk of developing T2DM who used
metformin and lifestyle modification in a diabetes prevention program and found there
was a 58% decreased risk of overt diabetes in the metformin group as compared to the
lifestyle and placebo groups. It was also shown that a significant (p=0.038) interaction
between weight loss and glucose does exist (Maruthur et al., 2013). The study
demonstrates the effectiveness of metformin alone in overt diabetes prevention and its
ability to potentiate the effectiveness of lifestyle modification when added to a treatment
plan. The implication of the study to practice is that metformin can be used
independently as a monotherapy or in conjunction with another intervention to prevent
overt diabetes in individuals at risk.
The DPPRG (2012) revealed a reduced body weight by 7%, weight
circumference, and waist circumference in the metformin group compared to the placebo
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(DPPRG, 2012). Gastrointestinal symptoms were seen among the metformin group at the
beginning of the intervention but subsided over time. The metformin group maintained
weight loss when evaluated during follow-up (DPPRG, 2012). The incidence of diabetes
was reduced by 34 % in the metformin and 18 % in the lifestyle group as compared to the
placebo (DPPRG, 2012). The study supports the project by showing that early treatment
initiation with metformin as recommended by the diabetes management algorithm for
individuals at risk helps gain efficient glucose control and weight management.
Herman (2015) compared the cost efficiency of lifestyle changes, metformin, and
placebo in a diabetes progression prevention program. There was a reduction in
prevalence of diabetes rate by 34% in the lifestyle group and 18% in the metformin group
as compared to the placebo group (Herman, 2015). It was also discovered that the
lifestyle modification and metformin interventions were more expensive than the placebo
intervention, but their costs were offset by reductions in the costs of noninterventionrelated medical care. Metformin alone as an intervention has the potential to delay the
progression of T2DM to u pto 10 years and the progression can be further extended up to
18 years when combined with diet and exercise (Herman, 2015). The implication of the
study to clinical practice is imperative because patients can be managed with metformin
in spite of their ability to comply with lifestyle modifications and delay the progression of
the disease.
De Kreutzzenberg et al (2015) assessed the impact of metformin in modifying the
alleged effectors of longevity in peripheral mononuclear cells of patients with
prediabetes. Pre-intervention and post- treatment anthropometric and metabolic
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parameters were collected for comparison (De Kreutzenberg et al., 2015). Metformin
effectively prevented the progression of prediabetes to overt diabetes among the subjects
and also significantly blunted inflammation, improved cell survival, and exerted
anticancer effects by suppressing the mammalian target of rapamycin (mTOR)/S6K1 axis
(De Kreutzenberg et al., 2015). Metformin targets AMP-activated dependent kinase
(AMPK) (see definition of terms) and thereby increases cellular resistance to stress,
inflammation, and aging (De Kreutzenberg et al., 2015). De Kreutzenberg et al. (2015)
said that metformin delays progression of T2DM; it also suppresses the aging process at
the same time. Increase in age is one risk factor for developing T2DM. The older an
individual, the higher the risk of developing T2DM (De Kreutzenberg et al., 2015).
Perreault et al. (2012) conducted a randomized clinical trial to compare the impact
of lifestyle changes with metformin, lifestyle only, and placebo in the progression of prediabetes to overt diabetes. The outcome revealed that the lifestyle and metformin group
had a higher number of participants that returned to normal glucose regulation (NGR) as
compared to lifestyle alone and placebo groups (Perreault et al., 2012). The conclusion of
the study also supports the effectiveness of metformin when combined with other
interventions such as lifestyle modification. The study implies that adding metformin to
the treatment plan of patients with difficulty managing lifestyle modification is an
imperative implication for clinical practice to attain the best clinical outcome in the
targeted population.
Malin et al. (2012) evaluated the combination of exercise with metformin (EM),
to exercise (E) and metformin (M) independently, placebo (P), and placebo with exercise
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(PE) in delaying the progression of pre-diabetes to overt T2DM. The result showed an
overall increase in insulin sensitivity (p < 0.05) relative to the control group and average
rise of 25-30% higher in insulin sensitivity among the PE group as compared to EM or
with metformin alone (Malin et al., 2012). The researchers observed that adding
metformin heightened the full effect of exercise in the metformin and exercise group
(Malin et al., 2012). The study affirms the efficiency of metformin in delaying
progression of T2DM as a monotherapy or as an adjunct to other intervention such as
increase physical activities.
Rhee et al (2010) examined the percentage of individuals that could benefit from
metformin treatment based on the recommendation of the ADA consensus panel in
delaying type 2 DM or preventing its occurrence. The ADA recommends that individuals
with both impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), along
with one additional risk factor such as age 60 years, BMI greater than 35 , family history
of diabetes in first-degree relative, elevated triglycerides, reduced HDL cholesterol, or
A1C 6.0% should be considered for treatment with metformin, lifestyle modification,
weight loss and physical activity (Rhee et al., 2010). It was found 1 in 12 individuals in
the target populations met the criteria for consideration of metformin (Rhee et al., 2010).
The findings of the study outcomes for clinical practice supports the project that early
identification of individuals at risk of developing T2DM and the need to initiate treatment
promptly to delay the progression of the disease is significant. An effective primary
prevention of T2DM would reduce morbidity, mortality, and financial constraint related
to its complications (Rhee et al., 2010). The outcome of the investigation supports the use
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of metformin treatment for diabetes prevention or delay of its progression as an
imperative clinical implication for practice (Rhee et al., 2010).
Viskochil, Malin, Blankenship, and Braun (2017) conducted a 12 weeks study to
determine the effect of metformin alone (M), metformin combined with exercise (ME),
placebo alone (P), and exercise with placebo (EP) on peripheral insulin sensitivity. A preand post-intervention fasting plasma proinsulin, C-peptide, insulin, and glucose were
collected. Hepatic insulin extraction, insulin clearance, body weight, and cardio
respiratory fitness were also measured. The result shows fasting proinsulin was
unchanged following P and EP. However, a significant increase insulin clearance and a
decrease fasting proinsulin were seen with M and even greater after EM. Insulin
clearance was significantly greater following M and EM but was unchanged in P or EP
(Viskochil et al., 2017). The study indicates that metformin combined with exercise
training reduced circulating proinsulin, and increased insulin clearance. The outcome not
only supported the hypothesis that adding metformin to exercise may attenuate the
training effects of exercise but also a clear indication for clinical use of metformin in the
management of T2DM to achieve desired outcome (Viskochil et al., 2017).
Mangahas, Huang, Neher, & Safranek, (2013) performed a systematic analysis of
three meta-analyses to determine the effectiveness of metformin in preventing diabetes in
adults at risk of developing diabetes. The analysis demonstrated that metformin
significantly reduced the risk of the at-risk patient from developing overt diabetes as
compared to the placebo group. A long-term follow-up of the patients in the Diabetes
Prevention Program (DPP) also indicates that metformin could delay the progression of
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T2DM to overt diabetes for as long as 10 years (Mangahas et al., 2011). The study also
showed that young adults ages 25-44 could benefit more from lifestyle modification
when combine with metformin than exercise alone. It was also concluded that patients
ages 65 years and above could benefit more from diet and exercise that could young
adult. Hence, the ADA strongly recommends utilization of metformin to prevent T2DM
in patients at risk despite lifestyle modification (Mangahas et al., 2011). The evidence
strongly supports and reinforces the impact of incorporating metformin for effective and
efficient management of T2DM based on the algorithm. The outcome of the study also
showed that combination of metformin and exercise is more beneficial to deter the
progression of T2DM in adult with high risk of developing T2DM from overt diabetes.
Metformin as a monotherapy or in conjunction with other therapy to delay the occurrence
or progression of T2DM is well researched and presented a clear implication for clinical
practice that could result in effective management of T2DM in primary settings
(Mangahas et al., 2011; Viskochil et al., 2017; Rhee et al., 2010).
Evidence Generated for the Doctoral Project
Participants
The target population for the project was adults, male and females ages 40 and
above, who have a BMI of greater than or equal to 25, family history of diabetes, with or
without existing medical history of hypertension, hyperlipidemia, prediabetes, and
recently diagnosed in the last 6 to 24 months as T2DM non-insulin dependent. A
randomized review of the EMR was performed at the project site to identify individuals
that meet the inclusion criteria. Exclusion criteria include individuals diagnosed with

37
T2DM for more than 24 months and on insulin therapy for diabetes management,
pregnant, and history of mental health. The ability to intervene at the preventive stage of
the disease process could prevent overt diabetes in individuals at high risk of developing
the disease and prevent the individuals recently diagnosed from developing further
complications related to the disease.
Procedures
The execution of the project cannot take place without the approval of the Walden
IRB. After the approval of the Walden IRB (Approval #: 03-23-18-0653019) the
identified potential participants who met the inclusion criteria were contacted for their
consent and participation in the diabetes education. The diabetes education was
conducted on Monday and Tuesday of the month that the organization was screening for
admission of new patients to the clinic. The clinical director suggested those days to be
the best period for the diabetes education, because there would less clinical activities on
those days and the staff would be available to help organize the sessions. The educational
sessions were held in the organization’s conference room in the morning before lunch
time.
On the first day of the educational session, the participants were seated in the
conference room as they arrive at the clinic. A pen and a paper copy of the consent were
presented to each participant. It was collected and kept in a folder labeled “consent” and
kept on the table. After the participants signed the consent, they were given the pre-test
questionnaire (see Appendix E) and a pen to complete it. Because the pre-test and the
post-test (see Appendix E) were the same sets of questionnaires, the word pre-test was
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circled, and the participants filled out the questionnaire with a pen. I was available in the
conference room for any questions by the participants as they fill out the questionnaires.
The result of the pre-test was used to establish their baseline knowledge of diabetes. The
questionnaires were kept anonymous and participants’ identification was not required.
The participants placed their completed pre-test questionnaire in the folder labeled “PreTest Questionnaire”.
The diabetes education was presented in a power point via the organization’s
projector in both English (see Appendix F) and Spanish (see Appendix P). I presented the
English version of the teaching session and Marlin, who is a member of the project team
and the Spanish interpreter for the organization, presented the Spanish version while I
stood by for questions. At the end of day one of the program, participants were given a
copy of the diabetes pamphlet (see Appendix F; Appendix P) with the same content
delivered based on their language preference. Participants were encouraged to return on
the second day of the program with any questions or concerns they may have regarding
the subject discussed or about diabetes in general.
On the second day of the educational session, the first few hours were used to
address any questions or concerns participants had regarding diabetes. The information
presented the previous day was reinforced to the participants in English by me and in
Spanish by Marlin. Then the post-test (see Appendix E) with the word posttest circled,
was distributed to the participants. The participants completed the posttest with a pen.
Both Marlin and I remained in the room in case there were any questions. The
questionnaires were kept anonymous and participant identification was not required. The
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participants placed the completed posttest questionnaire in the folder labeled “Posttest
Questionnaire”. The consent, the pre-test, and the posttest folders were taken to the
director’s office where they were locked inside a locked cabinet.
The results of the pre-test and post-education were compared by the director and
me. The total number of correct answers before the diabetes education session was
compared to total number of the correct answers after the educational session to ascertain
the changes in the participants’ knowledge of the subject matter. The expected successful
outcome of the diabetes education was a score of 90% or greater on the answered posttest
questionnaire. A result below 90% would have called for a repeat of the diabetes
education which would have been scheduled for the next organization’s screening period.
However, participants were also encouraged to follow up with their primary care provider
for screening and management as soon as possible. The patients’ knowledge deficit
related to diabetes was identified as a major contributing factor to the late diagnosis and
lack of effective management of T2DM in the target population. The lack of literacy
related to the disease becomes the driving force to heighten the patients’ knowledge and
awareness of the disease.
Instrument
The pre- and post-test (see Appendix E) was developed by myself from the NDEI
based on the diabetes teaching recommendation by the ADA, to evaluate whether the
diabetes educational session will improve the participants’ knowledge of diabetes, the
risk factors, and the complications related to the disease. The questionnaire was
developed to meet the educational need of the target population in accordance with the
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ADA teaching guidelines to support its validity and reliability. The learning tool
described diabetes in simple English and Spanish languages at a fifth-grade level for
maximum understanding by the participants and other readers.
Protections
The principle of Health Insurance Portability and Accountability Act (HIPAA)
was strictly adhered to, to safeguard the participants’ privacy. All the documents were
maintained in a locked cabinet inside the director’s private office at all times. The data
transcribed from the raw data collection was stored in a Microsoft word folder named
“Pre-and Posttest Results” in the organization’s computer system. Access to the
documents and data were limited to the project team members only. These authorized
individuals were assigned a password for accountability and security.
Analysis and Synthesis
The first objective of the project was to establish use of the diabetes algorithm as
the standard of care for the management of patients diagnosed with T2DM and patients at
high risk of developing T2DM at the project site. To effectively analyze the providers’
compliance with the guidelines, the number of patients with diabetes related
complications such as cardiovascular disease, hyperlipidemia, and peripheral neuropathy
receiving treatment based on the traditional guidelines was collecetd over a period of
three months before the implementation of the algorithm. Then the number was
compared to the number of patients with diabetes related complications such as
cardiovascular disease, hyperlipidemia, and peripheral neuropathy treated based on the
algorithm for a three-month period after implementation of the algorithm. The impact of
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the guideline in the effective management of T2DM in the target population was
determined by comparing a 3-month period prior to implementation of the algorithm to 3month period after implementation of the algorithm.
The second objective was to increase the awareness of patients at risk of
developing T2DM about the disease process and its management. A power point
presentation was delivered to the identified participants to enhance their knowledge of the
disease and its complications. A one group pre-and post-test was used to analyze the
influence of the teaching on patients’ knowledge of the subject discussed. The SPSS
version 24.0 was used to analyze the paired t-test to evaluate the differences between the
pre- and post-tests.
Summary
The project site has experienced a substantial level of treatment failure of patients
with T2DM due to lack of standardized clinical guidelines for the treatment of the target
population. The ongoing treatment failure and its impact cannot be over emphasized.
Hence, the need for a robust and standardized evidence-based practice to lessen the
severity of the problem and its impact on clinical outcome is highly imperative. The
focus of the project was to explore the hypothesis whether early initiation of treatment
with metformin based on the AACE and the ACE diabetes management algorithms delay
the progression of T2DM in individuals with high risk of developing the disease and
prevents complications in individuals diagnosed with the disease. An extensive literature
review was completed to validate its reliability and validity, and to ensure the
effectiveness of the type 2 DM algorithm in the management of patients with T2DM.
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Databases PubMed, MEDLINE, CINHAL, National Institutes of Health (NIH), CDC,
and the Cochrane Library via Walden University were used to conduct the review of
literature. The analysis and synthesis of the project was performed in two parts. First, to
compare the number of patients started on metformin based on the algorithm for three
months prior to the intervention and compared the number with post intervention result.
Second, a one group pre-and post-test would be utilized to analyze the learning outcome
of the diabetes teaching among the participants. The enormous impact of early
identification of individuals at risk of developing type 2 DM and initiation of preventive
measure with metformin based on the diabetes algorithm is indisputable to the prevention
of the progression of the disease and its complications.
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Section 4: Findings and Recommendations
Introduction
The primary purpose of the DNP project was to implement the diabetes
management algorithm as the standard of care for patients with T2DM at the project site
based on AACE and ACE guidelines, and increase patients’ knowledge of the disease, its
process, and complications. A Power Point presentation including the clinical
recommendations developed based on the AACE and ACE guidelines was sent to all the
care providers at clinic via the clinic group email address. Patients with diabetes-related
complications such as cardiovascular disease, hyperlipidemia, and peripheral neuropathy
who received treatment based on the traditional guidelines for the period between January
and March was collected and compared to the number of patients with diabetes-related
complications such as cardiovascular disease, hyperlipidemia, and peripheral neuropathy
based on the new guidelines for the period between April and June. Also, an extensive 2day diabetes education program delivered in both English and Spanish languages was
provided to patients older than 40 who had a high risk of developing T2DM and were
newly diagnosed within the last 6 months. To assess the participants’ baseline knowledge
of the subject, a pre-test was given before the diabetes educational sessions on day one
and a posttest was provided on day two to determine the change in the participants’ level
of understanding of T2DM. In this section, the findings, implications, recommendations,
contributions of the doctoral project team, strengths, and limitations of the project will be
discussed.
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Findings and Implications
The practice focused question was: Would early initiation of treatment with
metformin based on the AACE and the ACE diabetes management algorithms delay the
progression of T2DM in individuals with high risk of developing the disease and prevents
complications in individuals diagnosed with the disease? There were two objectives for
the project. The first objective was to implement the diabetes algorithm as the
standardized management guidelines to promote initiation of early treatment in
individuals at risk of developing T2DM and prevent complications in the individuals
diagnosed. The second project objective was to increase the awareness of patients at risk
of developing T2DM regarding the disease process and its management.
A Power Point presentation including the clinical recommendations developed
based on the AACE and ACE guidelines was sent to all the care providers at the clinic
via the clinic group email address on March 27, 2018. Two weeks later, 70% (13 of the
18 volunteer providers) of the clinicians responded. During the providers’ quarterly
meeting in April, the AACE and ACE guidelines was formally introduced by the director
to the providers as the clinic’s clinical guidelines to be used by providers for management
of patients with T2DM or at risk of developing the disease based on the algorithm. The
clinic’s computer system Athena (see definition of terms) is now equipped with screening
features that would prompt providers to explore more from patients with a family history
of T2DM during the initial encounter. Providers were also provided with the CDC
prediabetes screening test by the NDPP (see Appendix A) and the patient risk assessment
tool by the ADA (see Appendix B). All these resources were made available to providers
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at the project site to promote early identification of individuals at risk, prompt treatment
initiation to curb treatment failure, and ease the transition from the traditional guidelines
to the evidence-based diabetes algorithm.
To analyze the providers’ compliance new guidelines for the management of
patients with T2DM, the number of patients with diabetes-related complications such as
cardiovascular disease, hyperlipidemia, and peripheral neuropathy receiving treatment
based on the traditional guidelines from the months of January through March prior to the
implementation of the algorithm was compared to the number of patients with diabetesrelated complications such as cardiovascular disease, hyperlipidemia, and peripheral
neuropathy treated based on the algorithm for the months of April through June after
implementation of the algorithm. The result of the review from January through March
yielded 36 patients diagnosed with T2DM who also had hypertension, hyperlipidemia,
and/-or peripheral neuropathy. Of the 36 participants, 21 (58.3%) were females and 15
(41.7%) were males. Ages ranged from 37 through 62, with an average age of 48.3
years. It was found that the majority had hypertension, neuropathy, hyperlipidemia, and
just less than half of the group had a combination of hypertension, hyperlipidemia, and
neuropathy. An average of 61.8% of the participants has one or more diabetes-related
complications (see Table 1).
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Table 1
Descriptive Statistics for Age of the Study Participants Pre- intervention/Implementation
(n = 36)
Frequency

Percentage

12

33.3

46 to 50 years 13

36.1

≥ 51 years

11

30.6

Female

21

58.3

Male

15

41.7

Yes

31

86.1

No

5

13.9

Yes

18

50

No

18

50

Yes

24

66.7

No

12

33.3

Age
≤ 45 years

Gender

Hypertension

Neuropathy

Hyperlipidemia
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The post intervention review of EMR was performed for the months of April
through June. The result yielded 46 participants. The age of the participants ranged from
35 to 66 with an average of 45.5. Among them were 28 (60.9%) females and 18 (39.1%)
males. The participants were evaluated for diabetes related complications that include
hypertension, hyperlipidemia, and neuropathy. These diabetes-related complications were
averaged at 34.06 among the participants (see table 2).
Table 2
Descriptive Statistics for Age of the Study Participants Post Intervention/Implementation
(n = 46)
Frequency

Percentage

≤ 45 years

20

43.5

46 to 50 years

10

21.7

≥ 51 years

16

34.8

Female

28

60.9

Male

18

39.1

Yes

11

23.9

No

35

76.1

13

28.3

Age

Gender

Hypertension

Neuropathy
Yes

48
No

33

71.7

Yes

23

50.0

No

23

50.0

Hyperlipidemia

The comparison of the pre-and post-intervention of diabetes related complication
was performed to evaluate the effective utilization of the diabetes management algorithm
by the providers. During the pre-intervention EMR review, 31 (86.1%) of the participants
were diagnosed with hypertension, 18(50.0%) with neuropathy, and 24 (66.7) were
diagnosed with hyperlipidemia while the post-intervention shows 11(23.9%), 13 (28.3%),
and 23 (50.0%) respectively (see Figure 3).

Figure 3. Pre and post implemetation of diabetes algorithm.
A comprehensive diabetes management educational session was held at the
project’s site. After an extensive randomized review of the EMR, 37 individuals were
found who met the inclusion criteria. Of these 37 individuals, only 16 responded to the
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invitation to participate in the diabetes education. It’s not surprising for one to wonder
why the participation rate was less than 50% of the individuals who met the inclusion
criteria. One of the reasons is lack of transportation. The clinic is situated in the
downtown of the city where public transport is not available in the area, and individuals
are dependent on their own private vehicle, which may be difficult for them to fuel. The
target population has a very low socioeconomic status such that not all basic needs are
available to them. Most of the patients depend on families and friends to bring them to
the clinic for their scheduled appointment. It is not uncommon for patients to cancel
appointments in successions due to lack of transportation to the clinic. For the female
patients, the lack of childcare is another common reason for them to miss their
appointment. These are some of the reasons why it is difficult for some of these qualified
participants to make a commitment for the diabetes education.
The educational session was conducted for two days. On day one of the session,
10 female and six male participants were present for the pre-test and the diabetes
education (see Table 2). However, only 14 participants partook in the posttest on the
second day of the educational session. The analysis and computation of the paired t-test
for the pre-test was computed based on the number of participants who completed both
the pre-test (n = 14) and the posttest only. The average age of the participants based on
the number of participants that completed the two sessions was 48.5 years (SD = 13.02, n
= 14; SD = 4.9, n = 14) ranging in age 40 to 57. SPSS version 24.0 was used to analyze
the paired t-test and to evaluate the differences between the pre and posttests. Analysis of
the diabetes education program is provided (see Table 3). The mean score on the pre-test
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was 56.91 while the score on the posttest was 90.72. The participants’ average pre-test
and post-test score respectively was 56.91% and 90.72%, an increase of 34.14%, leading
to 90.72% average score.
Table 3
Paired Samples Statistics Diabetes Education Pre and Post test Scores
N

Mean

Standard Deviation

Pre-Intervention Score

14

56.91

13.02

Post-Intervention Score

14

90.72

6.46

There was a mean difference of 34.14 between the participants’ pre-test diabetes
knowledge as compared to their knowledge on the post-test (see Table 4). Conduction of
the paired difference of the pre-and posttest diabetes education yielded a p < 0.05,
demonstrating that the outcome of knowledge was not impacted by the number of the
absentees. The remarkable increase in the posttest average diabetes education score
indicates a need for diabetes education in the target population. T2DM is very complex
and the results support that ongoing, adequate, and efficient diabetes education is
necessary for the patient’s effective self-care management.
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Table 4
Paired Samples Statistics for Diabetes Education Pre/Post-Intervention Test Scores (n =
14)
95% Confidence
Interval
Score

N

Mean Std. Dev. Lower

Pre Intervention

14 56.91 13.02

49.84

63.35

Post Intervention

14 90.72 6.46

87.35

94.11

26.06

42.21

Post compared to Pre 14 34.14 13.99

Upper

t

df

p

9.13 13 <0.001

Implications
The target population is faced with a significant knowledge deficit related to their
T2DM, its disease process, and complications. The wide gap in knowledge indicates a
need for ongoing assessment of patients’ knowledge of the disease and corresponding
teaching sessions by clinicians. The goal is identification of individuals at risk of
developing T2DM with prompt intervention ensuing. However, in most cases these
individuals are not identified until the overt disease phase is manifested (Forouhi &
Wareham, 2014). In this case the goal is to delay the progression of the disease and
thereby prevent complications. T2DM is a multifaceted, chronic, and complex disease
such that patients’ adequate understanding of the disease is imperative for effective
management of the disease. The patients’ ability to understand the disease will not only
support their skills-based learning but it will enhance their sense of empowerment to selfcare management (Baptista et al., 2016).
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Lack of patients’ awareness of T2DM has been identified as one of the major
contributing factors to poor patients’ health care outcome in the target population. Thus,
to achieve efficient transition of care from the clinical setting to the home environment,
adequate patient education that empowers the patients and emphasizes their role in
effective self-management is necessary for successful achievement of the individual
patient’s desired clinical outcome.
Recommendations
Early identification of individuals at risk of developing T2DM based on their
family history, BMI, and age is key to delaying the disease progression and prevention of
complications. One of my recommendations is for the providers to adopt a culture of
standardization of care based on the clinical guidelines that support prophylaxis and early
treatment of the target population. Healthcare insurance organizations such as Medicare
and Medicaid recommend standardized clinical guidelines as a benchmark for provision
of care and development patients’ plan of care by providers. According to Krieger (2008)
standardization of care at all levels is indisputable to eliminate the proximal-distal
phenomenon. The phenomenon not only creates a class and racial inequality that
differentially affects the living standards, working conditions, and environmental
exposures of the dominant and subordinated classes and racial/ethnic groups, but also
promotes health care disparities (Krieger, 2008). Standardization of care for the target
population is imperative as the clinic is staffed by volunteer providers which mean that
the probability of the patients seeing the same provider at each clinic visit is less than
50%. The use of the diabetes management guidelines as a standard of care for the target
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population will not only eliminate inconsistency of care among providers, it will also
promote continuity of care among the target population despite the instability of
providers’ availability at the project site.
Early screening of individuals at risk is another key recommendation. Individuals
with a strong family history of T2DM, age 40 and above, even without elevated BMI
should be screened for the disease. It was established that an individual could have the
disease for as long as seven years before the first symptom emerged (Forouhi &
Wareham, 2014). The new insight gained about T2DM that one can have the disease for
about 7 years before the onset of the initial symptoms, explains the reason why most
patients already have complications related to the disease at the time of initial diagnosis.
From an epidemiological stand point, primary prevention is the goal of effective disease
management.
Adequate and efficient patient education must be ongoing. The existence of such
an educative forum will enable patients to make an informed decision towards their
health and develop a sense of involvement. Development of a collaborative care approach
between patients and their providers, along with a customized patient-centered plan of
care, are imperative to a successful clinical outcome and attainment of a positive health
care outcome in the target population.
Contribution of the Doctoral Project Team
The contribution of the doctoral project team cannot be over emphasized.
According to Thomas et al. (2008), project planning and team development are integral
parts and processes of a project and must be developed and initiated simultaneously with
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the project. After the approval of the project by IRB, I as the project manager met with
the project team members who consisted of my preceptor who is also the sponsor, the site
care coordinator and the Spanish interpreter to decide when the diabetes education could
take place. During the meeting, it was agreed upon to have the teaching done on the 2nd
and 3rd of April, and every team members’ role was reinforced for clarity.
The project site care coordinator coordinates the EMR review and serves as the
liaison between the project team, project manager and the patients. As the project
manager, I also worked closely with the care coordinator during the EMR review as well
as reaching out to potential participants via telephone. The Spanish interpreter was the
one that helped interpret in Spanish. My sponsor, who is the director of the organization
was responsible for safety of all the correspondence. The consent, the pre-test, and the
posttest folders were kept in a locked cabinet in his office. The project was a success
because of the committed team members.
Strengths and Limitations of the Project
One of the strengths of the project was that it gave the target population the
opportunity to reassess their knowledge of T2DM. It allows the participants to have
clarity about the disease process and the potential complications. The diabetes education
was an eye opener to the participants as majority of them was not aware of the fact that
T2DM is a medical condition that affects the diagnosed systemically. The project was
held over a two-day period which allowed the participants ample time to digest the
information presented and not be over saturated with information in just few minutes.
The format allowed for more questions from the participants and provided enough time to
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allow every participant’s questions to be answered. Also, the Power Point presentation I
developed based on the -AACE and ACE-guidelines shared with the providers did not
only enhance their knowledge of the disease process but also provided them with the
standard of care evidence-based practice guidelines related to T2DM. The project
enabled the providers to embrace prophylaxis measures towards the disease and not just
focus on treatment modalities only (Crandall et al., 2008; Boyle et al., 2010).
The only limitation of the project is that the outcome of the project cannot be
generalized to another hospital, unit, or different patient population. The project site is a
small community-based clinic with an annual patient population of about 3200 and
majority are Spanish speaking. The sample size and the combination of the participants
may not have truly represented the general population for the outcome of the project to be
generalized. Hence, use of the project outcome at a similar organization is suggested. A
replication of the project can be conducted in an environment with a more diverse and
larger population sample to enhance the generalizability of the project (Mishra,
Lalumière, & Williams, 2017).

56

Section 5: Dissemination Plan
Introduction
The purpose of this DNP project was to alleviate treatment failure in patients
diagnosed with type 2 DM at the project site. Prior to the project, the clinic was using
traditional guidelines for the management of patients with type 2 DM. Based on the
traditional guidelines, patients were not screened nor treated prophylactically unless they
were symptomatic, which is defined as having a non-healing wound, frequent infections,
sudden weight gain or loss, a HbA1c value greater than 10% in a routine blood test,
diabetic neuropathy, and elevated urine protein. A retrospective review of patients’
medical records over the last 5 years demonstrated that more than 85% of the patients
with type 2 DM were diagnosed late and analysis of data from the months of January
through March showed 61.8% of patients had diabetes related complications.
During my investigation, I discovered that to alleviate the problem of treatment
failure in the target population two things must be done. First, was the establishment of
standards of care based on the AACE and the ACE diabetes management algorithm.
Secondly, an educational intervention to educate patients about T2DM, its disease
process, and complications needed to be developed. The results of the pre-and posttest
diabetes education program showed an increase of 34.14%. The project will be
disseminated via electronic media to similar community-based clinics, pharmaceutical
stores, the Florida diabetes prevention center, and Florida public health center in Destin.
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The manuscript will be developed for consideration for publication in the American
Journal of Diabetes (AJD).
Analysis of Self
Scholar
According to the AANC (2006) development and evaluation of new practice
approaches based on nursing theories and theories from other disciplines are some of the
core elements of a DNP-prepared nurse. As a DNP-prepared nurse scholar, I am equipped
to assess an organization or a system for potential improvements or changes that could
enhance the productivity of the organization and the population served. It is also vital for
me as an agent of change and empowerment to develop and implement health promotion
and disease prevention activities for individuals, aggregates, and population. Health
promotion and population health are imperative for positive global wellbeing and health
outcomes (Kumar & Preetha, 2012).
Practitioner
Organizational and systems leadership for quality improvement and systems
thinking is another key component of a DNP prepared practitioner (AANC, 2006). I
firmly believe that standardization of practice based on accredited guidelines is
imperative to achieve universal population positive health outcomes.
Long-Term Goal
My long-term goal as a DNP-prepared nurse is to be actively involved in health
care politics and policies. My goal is to start with my local constituency and then
continue to Congress. Health care policy for advocacy in health care is another essential
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requirement of a DNP-prepared nurse (AACN, 2006). The ability to facilitate health care
services delivery and engagement in practice to address health care needs is imperative
(McWilliams, 2009).
My exposure to the population served at the project site had a significant impact
on me related to health care policy. The majorities of the patients were of low
socioeconomic status and had limited access to health care due to lack of health care
insurance. In Destin, Florida where the clinic is located, most of the available
employment is either part-time or seasonal. Employees may work as though they are fulltime but without full-time benefits because their employment status is part-time. In this
case, employers have no obligation to provide those employees with medical insurance
because they are considered part-time. Non-profit clinics such as my project site are left
to bridge the gap. This experience has inspired to encourage other scholars to get
involved in politics that could influence change in healthcare legislation.
Lack of health insurance has been identified as the major reason preventing adults
from seeking health care in a timely manner. They have less access to recommended care,
receive poorer quality of care, and experience worse health outcomes than insured adults
(McWilliams, 2009). According to the AACN (2006), political activism and commitment
to policy development are central elements of professional nursing practice. As a DNP
graduate I am equipped with the ability to assume a broad leadership role on behalf of the
population served as well as the nursing profession to influence change in terms of health
disparities, cultural sensitivity, ethics, the internationalization of health care concerns,
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access to care, quality of care, health care financing, and issues of equity and social
justice in the delivery of health care.
My ability to engage in leadership that integrates and institutionalizes evidencebased clinical prevention and disease management is indispensable. As a captain and
element leader in the United States Air Force (USAF) and a clinical primary care
provider, my leadership skills have prepared me to be one of the best in the nursing
profession. These experiences have also paved the way for my ongoing professional,
leadership, and scholarly growth.
Project Manager
Even though the process of project implementation could be very challenging, it
is vital to successful implementation of a change into practice. According to the AACN
(2006), clinical prevention and population health for improving the nation’s health is one
of the academic requirements for the DNP. Acquired clinical knowledge became the
driver for me to assess the clinic’s needs related to treatment failure in patients with
T2DM at the project site. Identification of the clinical problem and the stakeholders were
critical elements of the project. Involvement of the representatives from the target
population is not only essential to create a sense of connection and ownership of the
program among the target population, but also promote support for the implementation,
acceptance, and sustainability of the programs (Hodges & Videto, 2011). Having a
strategic plan is a critical part of project development and implementation (ASCO, 2009).
The process may become cumbersome along the way and one may not be able to
absolutely control the future of the program at that point but having a strategic plan could
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help establish a sense of re-direction and the ability to maximize the available options to
influence the environment and attain the project outcome (ASCO, 2009).
Completion of the Project
Challenges and Solutions
Like any other project, the completion of the DNP project was not without
challenges. One of the challenges faced during the execution of the project was choosing
the right topic. As a provider, I knew I wanted to develop a project related to health
promotion and disease prevention because most of the chronic diseases that I deal with at
the clinic can be prevented with effective and efficient intervention. I had numerous
ideas, but the prevention of T2DM in individuals at risk became clear to me due to my
personal life experience with diabetes. The need to focus on the target population became
stronger when I got to my clinical site. I have experienced cases of treatment failure in
my own practice, but it was nothing compared to what I saw at the clinical site. I started
exploring the literature to enquire more about the clinical problem and about what can be
done to alleviate it.
The review of the literature was another challenge that I faced during the project.
I used the databases PubMed, MEDLINE, CINHAL, NIH, CDC, and the Cochrane
Library via Walden University. It took me about one week to sort through about 2800
articles generated by my initial search to obtain the specific literatures that support my
topic. At the end the result of the literature review gave me more confidence that I was in
the right direction because of the numerous existing studies that supported the topic.
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Choosing the right methodology and theoretical framework was another
challenge. Although, I had an insight of what my project would be, I was unsure of my
method of data collection, how to evaluate the data, and how to theoretically present the
information. Materials from my research class such as McEwin and Wills (2014) and
others were used to overcome the barrier. Another challenge that I faced during the DNP
project was finding participants and avenues to perform the diabetes education.
Contacting the potential participants to participate in the project was harder than I
anticipated. The organization’s director and the entire staff were very supportive, and
they helped me throughout the process.
Insight Gained on the Scholarly Journey
Perseverance and dedication are the most important insight that I gained from my
scholarly journey. During my journey, I work as a full-time parent, active military
personnel, and as a clinical provider. Work and family life together can be very
challenging and become much more challenging when combined with full-time academic
work. They could be very overwhelming but having a very dedicated mentor is what
made the difference. Like a marathon runner, sometimes I felt like giving up, but I always
found the courage to continue until I reached the finish line.
Summary
The first purpose of the project was utilization of the diabetes algorithm as the
standardized guidelines of care for patients at high risk of developing T2DM to increase
the provider’s initiation of early treatment in the target population. A review of the EMR
over 3-month period revealed an average of 61.8% in diabetes-related complications
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among the patients diagnosed with T2DM in the last 24 months. These are conditions that
could have been prevented if treatment was initiated earlier. It was discovered that most
providers were not aware that T2DM could be existing in an individual for up to 7 years
before the presentation of the first sign and symptom. The lack of awareness of the
disease process by clinicians leads to delay in diagnosis and eventually resulted in
treatment failure in the target population.
The second purpose was to increase the awareness of patients at risk of developing
T2DM about the disease process and its management. The analysis of the diabetes
education showed a significant means difference of 34.14 from the pre-education and
paired difference yielded a statistically significant p < 0.05. An ongoing diabetes
education program is imperative in the target population to eliminate the knowledge
deficit related to the disease process and its complications. The ability of the target
population to understand that T2DM is a very complex disease that does not affect only
one area of the body, but every part of the body, will heighten their self-care management
treatment regimen. Most patients are gripped with fear of the unknown upon diagnosis
and are not able to comprehend the potential impacts of the disease onset in their lives.
Genetic awareness of the disease by individuals with strong family history and early
intervention to prevent overt diabetes cannot be overemphasized. The goals of the DNP
project were attained at the end of the project. The patients’ knowledge of T2DM was
enhanced and the providers’ use of the diabetes management algorithm as standard of
care has led to increase in early diagnosis and prompt intervention, thereby alleviating
treatment failure in the target population.
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Patient Risk Assessment
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Appendix B
Prediabetes Screening Test
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Appendix C
Follow Up Letter Template
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Appendix D
Pre Test/Post Test questions
The purpose of this pre-test/post-test is to evaluate whether this diabetes education
program improved the participants’ knowledge of diabetes, its risk factors, and
complications related to the disease.
1. What do you understand by diabetes?
a. Too much sugar in the body
b. Too much sugar in the blood
c. None of the above
d. I do not know
2. How many types of diabetes do exist?
a. 2.
b. 1.
c. I do not know
3. What conditions put one at risk for diabetes?
a. Age
b. Obesity
c. Family history of diabetes
d. All the above
e. None of the above
4. Identify other medical conditions that can be developed due to diabetes.
a. Blindness
b. Heart disease
c. Loss of extremities
d. Kidney failure
e. All the above
f. None of the above
5. What can you do when you think you are at risk
a. Do nothing
b. Talk to your doctor
c. Call your pastor
6. Can diabetes be prevented before it starts in people at high risk?
Yes □
No □
7. How can it be prevented?
a. Eat little or no food
b. Exercise every day
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c. Make healthy choice of food and increase physical activities
d. Follow your doctor’s treatment plan
e. c & d
8. How often does your doctor need to check your A1C when you are on medication?
a. Not at all
b. Every six months
c. Every three months.
9. How do you know when your blood sugar is too high?
a. Drinking a lot
b. Urinating a lot
c. Mouth feels like cotton
d. Losing weight for no reason
e. Feeling tired all the time
f. All the above
g. None of the above
10. What will you do when you feel that your blood sugar is high?
a. Call your doctor
b. Do nothing
c. Call your pastor
11. What will you do when you feel that your blood sugar is too low?
a.
b.
c.
d.

Do nothing
Drink juice like orange juice
call your doctor
b&c
(NDEI.org, n.d)
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Diabetes Education: English Version
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Definition of Diabetes
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Appendix G
Types of Diabetes
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Type 2 Diabetes
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Appendix H
High Blood Glucose
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Appendix J
Blood Glucose and Ketone Tests
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Appendix K
Diabetes Medications
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Appendix L
Changes in Blood Glucose Level
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Appendix M
Blood Glucose Maintenance Goals
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Support System
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Diabetes Education: Spanish Version
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Definicion De La Diabetes
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Tipo De Diabetes

90
Appendix R
Type 2 Diabetes
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Alto Nivel De Glucose En Sangre
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Appendix T
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Appendix U
Medicamentos Para La Diabetes
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